×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
LGVN – longeveron inc. - common stock (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
LGVN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
2/25
11:26 am
lgvn
Longeveron® Results of Phase 2b Clinical Trial Demonstrating Stem Cell Therapy Improved Condition of Patients with Age-Related Frailty Published in Cell Stem Cell [Yahoo! Finance]
Medium
Report
Longeveron® Results of Phase 2b Clinical Trial Demonstrating Stem Cell Therapy Improved Condition of Patients with Age-Related Frailty Published in Cell Stem Cell [Yahoo! Finance]
2/25
11:05 am
lgvn
Longeveron® Results of Phase 2b Clinical Trial Demonstrating Stem Cell Therapy Improved Condition of Patients with Age-Related Frailty Published in Cell Stem Cell
Medium
Report
Longeveron® Results of Phase 2b Clinical Trial Demonstrating Stem Cell Therapy Improved Condition of Patients with Age-Related Frailty Published in Cell Stem Cell
2/13
04:41 pm
lgvn
Longeveron appoints new CEO [Seeking Alpha]
Low
Report
Longeveron appoints new CEO [Seeking Alpha]
2/13
04:30 pm
lgvn
Longeveron® Appoints Stephen H. Willard as Chief Executive Officer
Low
Report
Longeveron® Appoints Stephen H. Willard as Chief Executive Officer
2/5
09:15 am
lgvn
Longeveron Applauds Passage of the Mikaela Naylon Give Kids a Chance Act and Reauthorization of Rare Pediatric Disease Priority Review Voucher Program
Medium
Report
Longeveron Applauds Passage of the Mikaela Naylon Give Kids a Chance Act and Reauthorization of Rare Pediatric Disease Priority Review Voucher Program
1/29
09:15 am
lgvn
Longeveron® Granted Japan Patent for Potency Assay Methods for Assessing Human Mesenchymal Stem Cells (MSCs)
Medium
Report
Longeveron® Granted Japan Patent for Potency Assay Methods for Assessing Human Mesenchymal Stem Cells (MSCs)
1/26
09:23 am
lgvn
Longeveron Announces FDA Grants Type C Meeting Ahead of Data Readout for Pivotal Phase 2 Clinical Trial (ELPIS II) Evaluating Treatment for Hypoplastic Left Heart Syndrome (HLHS) [Yahoo! Finance]
Medium
Report
Longeveron Announces FDA Grants Type C Meeting Ahead of Data Readout for Pivotal Phase 2 Clinical Trial (ELPIS II) Evaluating Treatment for Hypoplastic Left Heart Syndrome (HLHS) [Yahoo! Finance]
1/26
09:15 am
lgvn
Longeveron Announces FDA Grants Type C Meeting Ahead of Data Readout for Pivotal Phase 2 Clinical Trial (ELPIS II) Evaluating Treatment for Hypoplastic Left Heart Syndrome (HLHS)
Medium
Report
Longeveron Announces FDA Grants Type C Meeting Ahead of Data Readout for Pivotal Phase 2 Clinical Trial (ELPIS II) Evaluating Treatment for Hypoplastic Left Heart Syndrome (HLHS)
Date
Time
Symbol
Company Name
Action
%Chg
11/4/2025
04:05 pm
LGVN
longeveron inc. - common stock
MISS
Report
-1.0%
longeveron inc. - common stock
8/13/2025
04:05 pm
LGVN
longeveron inc. - common stock
BEAT
Report
-6.8%
longeveron inc. - common stock
5/8/2025
04:05 pm
LGVN
longeveron inc. - common stock
IN-LINE
Report
-5.7%
longeveron inc. - common stock
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/3
08:00 am
lgvn
Form PRE 14A Longeveron Inc. For: Mar 03
Medium
Report
Form PRE 14A Longeveron Inc. For: Mar 03
2/13
04:46 pm
lgvn
Form 8-K Longeveron Inc. For: Feb 09
Low
Report
Form 8-K Longeveron Inc. For: Feb 09
2/10
02:15 pm
lgvn
Form SCHEDULE 13G/A Longeveron Inc. Filed by: Lincoln Alternative Strategies LLC
Low
Report
Form SCHEDULE 13G/A Longeveron Inc. Filed by: Lincoln Alternative Strategies LLC
1/6
06:00 pm
lgvn
Form 4 Longeveron Inc. For: Jan 02 Filed by: Powell James Nathaniel
Medium
Report
Form 4 Longeveron Inc. For: Jan 02 Filed by: Powell James Nathaniel
1/6
06:00 pm
lgvn
Form 4 Longeveron Inc. For: Jan 02 Filed by: Locklear Lisa
Medium
Report
Form 4 Longeveron Inc. For: Jan 02 Filed by: Locklear Lisa
1/6
06:00 pm
lgvn
Form 4 Longeveron Inc. For: Jan 02 Filed by: Agafonova Nataliya
Medium
Report
Form 4 Longeveron Inc. For: Jan 02 Filed by: Agafonova Nataliya
1/6
06:00 pm
lgvn
Form 4 Longeveron Inc. For: Jan 02 Filed by: Blass Devin
Medium
Report
Form 4 Longeveron Inc. For: Jan 02 Filed by: Blass Devin
1/6
06:00 pm
lgvn
Form 4 Longeveron Inc. For: Jan 02 Filed by: Lehr Paul T
Medium
Report
Form 4 Longeveron Inc. For: Jan 02 Filed by: Lehr Paul T
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: